AbbVie
ABBV
#25
Rank
โ‚น48.374 T
Marketcap
โ‚น27,367
Share price
-0.59%
Change (1 day)
31.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): โ‚น551.98

According to AbbVie's latest financial reports the company's current EPS (TTM) is โ‚น546.89. In 2025 the company made an earnings per share (EPS) of โ‚น221.24 a decrease over its 2024 EPS that were of โ‚น226.36.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น551.98149.49%
2025โ‚น221.24-2.26%
2024โ‚น226.36-11.86%
2023โ‚น256.83-58.95%
2022โ‚น625.692.49%
2021โ‚น610.49121.58%
2020โ‚น275.51-44.7%
2019โ‚น498.2045.84%
2018โ‚น341.609.72%
2017โ‚น311.34-9.54%
2016โ‚น344.1816.28%
2015โ‚น295.99184.1%
2014โ‚น104.18-57.15%
2013โ‚น243.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น66.36-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,887 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,624 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น220.57-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น289.73-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น422.44-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น665.44 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น268.92-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น651.42 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA